Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 CAR T-cell therapy

Radiotherapy is potentially an important salvage strategy post-chimeric antigen receptor T-cell therapy (CART) but limited data exist. We reviewed 14 patients treated with salvage radiation post-CART progression (SRT). Most received SRT for first post-CART relapse (71%) to sites previously PET-avid...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Haematol
Main Authors: Imber, Brandon S., Sadelain, Michel, DeSelm, Carl, Batlevi, Connie, Brentjens, Renier J., Dahi, Parastoo B., Giralt, Sergio, Park, Jae H., Sauter, Craig, Scordo, Michael, Shah, Gunjan, Perales, Miguel-Angel, Palomba, M. Lia, Yahalom, Joachim
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7329607/
https://ncbi.nlm.nih.gov/pubmed/32135029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.16541
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados